Emerging viruses and transfusion.
The development of new technologies leads to the discovery of new viruses. For each of these new infectious agents, their possible relevance to blood transfusion needs to be assessed. The questions to be answered are transmissibility by transfusion, pathogenicity, prevalence in blood donors, persistence, and the availability of screening assays. Since 1995, three new viruses have been identified and extensively studied.
Allain
J P
JP
Dept of Haematology, University of Cambridge, United Kingdom. jpa1000@cam.ac.uk
D001803:Blood Transfusion / Q000592:standards; D021821:Communicable Diseases, Emerging / Q000097:blood / Q000517:prevention & control / Q000635:transmission / Q000821:virology*; D004266:DNA Virus Infections / Q000097:blood / Q000517:prevention & control / Q000635:transmission / Q000821:virology; D018067:Flaviviridae / Q000302:isolation & purification; D006525:Hepatitis, Viral, Human / Q000097:blood / Q000517:prevention & control / Q000635:transmission / Q000821:virology; D006566:Herpesviridae Infections / Q000097:blood / Q000517:prevention & control / Q000635:transmission / Q000821:virology; D019288:Herpesvirus 8, Human / Q000302:isolation & purification; D006801:Humans; D008403:Mass Screening; D022783:Torque teno virus / Q000302:isolation & purification; D065227:Transfusion Reaction; D014766:Viremia / Q000175:diagnosis / Q000635:transmission; D014777:Virus Diseases / Q000097:blood / Q000517:prevention & control / Q000635:transmission*